The Tudor Dixon Podcast: The Hidden Cost of SSRIs—Rosie Tilley Exposes the Reality of Post-SSRI Sexual Dysfunction
Date: October 17, 2025
Podcast: The Clay Travis and Buck Sexton Show (Special: The Tudor Dixon Podcast)
Host: Tudor Dixon
Guest: Rosie Tilley (PSSD advocate, survivor, founder of PSSD network)
Episode Overview
This emotionally powerful episode tackles a rarely discussed but increasingly critical topic: the long-term and often permanent sexual dysfunction that can occur after taking SSRI antidepressants, known as Post-SSRI Sexual Dysfunction (PSSD). Tudor Dixon interviews Rosie Tilley, a young woman who developed PSSD after being prescribed Lexapro during a challenging period, and who now leads advocacy and support for others afflicted by the condition. Together, they expose how little is known—or disclosed—about these enduring side effects and call attention to the lack of research, regulation, and support for victims.
Key Discussion Points & Insights
1. Rosie’s Story and First-Hand Experience with PSSD
- Background: In 2020, during COVID lockdowns, Rosie experienced depression and anxiety and was prescribed Lexapro (an SSRI) by her psychiatrist (04:53).
- Immediate & Lasting Effects: Short-term side effects on the medication were severe, but the most devastating was permanent sexual dysfunction, which never resolved after stopping the drug ([04:53], [06:51], [08:48]).
- “For the last five years, I have effectively been chemically castrated by this drug.” — Rosie ([04:53])
- Lack of Warning: Rosie was only provided with a vague, one-sentence warning about sexual side effects. She was told any problems would resolve upon stopping the medication, which proved untrue ([07:12], [08:36]).
2. Nature and Severity of PSSD
- Total Loss of Sexual Function:
- Rosie describes it as a light switch that’s been unplugged: “Even if I try…I literally am unable to feel anything. You essentially become completely asexual.” ([08:48])
- It’s much more than “low libido”; it’s physiological inability to feel arousal or sexual pleasure ([08:36]-[10:15]).
- Associated Symptoms: Emotional blunting, changes to perception and sensory experience, loss of happiness and excitement (“It’s like living with a chemical lobotomy.”) ([10:22], [55:26]).
- Familial & Social Impact: PSSD disrupts relationships, causing loss of intimacy, isolation, and emotional breakdown, sometimes leading to suicidal ideation ([18:18], [19:41]).
3. Failure of the Healthcare and Regulatory System
- Inadequate Warnings & Research:
- Most SSRI studies were only 12 weeks long; no long-term follow-up or assessment of persistent effects ([11:09]).
- No requirement for drug companies to monitor or report long-term side effects ([11:09]).
- Quoted: "No study has ever followed the course of SSRI-induced sexual dysfunction after a patient has stopped taking the medication." ([11:09])
- Dismissal and Gaslighting by Medical Professionals:
- Many doctors and psychiatrists deny the possibility of permanent effects; one even institutionalized Rosie for asserting her symptoms ([36:00]).
- “He wrote that I have ‘firm, fixed, delusional beliefs that the medication is causing side effects.’ It’s like writing, ‘She has a firm, fixed, delusional belief that the Pope is Catholic.’” — Rosie ([36:00])
4. Societal and Cultural Concerns
- Mass Medication & Crisis:
- America is the most medicated society in history, yet suicide rates remain high ([27:16]).
- Overprescription to youth and children, with little understanding of the risk ([13:41], [29:55]).
- Possible Underestimation of Sexual Dysfunction:
- Many who now identify as “asexual” or with abnormal sexual development may be suffering from undisclosed drug aftereffects ([29:55]).
- Correlation between rise in SSRI prescriptions and declining sexual activity among Millennials and Gen Z ([29:55]).
- Discussion Taboos:
- Talking about sexual dysfunction is rare and stigmatized, making advocacy and honest discussion challenging ([28:17], [45:50]).
5. Advocacy, Community, and Research
- The PSSD Network:
- Rosie founded a self-funded advocacy network to collect research, connect sufferers, and push for recognition ([42:24]).
- Lack of funding and institutional support; most efforts are grassroots ([42:24]).
- Barriers to Research and Awareness:
- Pharmaceutical industry lobbying, financial ties to psychiatrists, and public ignorance act as powerful obstacles ([42:24]).
Notable Quotes & Memorable Moments
-
On Loss of Sexual Function:
“If you consider your own libido and sexual arousal like a light switch going on, it’s almost like someone’s pulled the plug out of the wall and you turn the switch and nothing happens to the light.” — Rosie ([08:48]) -
On the Systemic Failure:
“The word ‘antidepressant’ is a really deceiving marketing tool… if these were called libido-blocking drugs, I don't think people would have the same response.” — Rosie ([27:32]) -
On Emotional and Social Impact: “If you remove happiness and pleasure and sex and love and joy and excitement, what is left? These aren't trivial things. This is what we are alive for.” — Rosie ([19:41]) “I remember…a friend messaged me, ‘If I killed myself because of this, people are going to say he had mental health issues…’ And that’s exactly how it was written after his death.” — Rosie ([21:31])
-
On Medical Gaslighting: “They made me feel like I was all alone for the longest time.” — Rosie ([36:00]) “He wrote that I have firm, fixed, delusional beliefs that the medication causes side effects…” — Rosie ([36:00])
-
On Permanent Damage and Lack of Accountability: “Telling someone you’re going to have a temporary effect is very different to having this for the rest of your life…once it transitions into a permanent change, it’s completely life-changing.” — Rosie ([33:08])
-
The Opioid Parallel and Call for Accountability: “I think this is as big as the opioid crisis. To say you have castrated people and you have taken away their ability to feel their sexual partner…that is criminal.” — Tudor Dixon ([33:08])
-
On the Need to Speak Out:
“If we don’t say anything, no one’s going to know about it.” — Rosie ([54:05])
Major Timestamps
- 04:27 — Rosie begins telling her story
- 06:51 — Permanent sexual side effects; “chemically castrated by this drug”
- 08:36 — What “chemical castration” means; physiological inability to feel arousal
- 10:15 — Possible brain/neural damage; inability to explain the mechanism
- 11:09 — Lack of long-term studies and warnings; regulatory loopholes
- 13:41 — Phenomenon of overmedication of youth and children
- 16:16 — Physical damage in men documented by research (fibrosis)
- 18:18 — The “hell on earth” of the PSSD community
- 19:41 — Emotional blunting, suicidality, and misattributed mental health diagnoses
- 27:16 — Medicating society and the paradox of persistent high suicide rates
- 29:55 — Correlation between SSRIs, asexuality, and generational sexual decline
- 36:00 — Rosie's encounter with medical gaslighting and psychiatric institutionalization
- 42:24 — Explanation of the PSSD Network; fundraising and advocacy challenges
- 50:00 — Tudor Dixon questions the actual benefits of SSRIs versus their risks
- 51:14 — Rosie's fears and changed expectations for her future
- 54:05 — Rosie’s motivation for advocacy, despite personal cost
- 55:26 — “Chemical lobotomy”—non-sexual neurological effects and lack of long-term data
Conclusion & Takeaways
This episode is a stirring exposé of both SSRI-induced sexual dysfunction and the systemic disregard for its victims. The conversation spotlights the gap between what pharmaceutical companies disclose and the reality experienced by patients—especially the young. Rosie’s testimony provides a raw, personal lens into a crisis affecting untold numbers who often suffer in silence.
Key Messages:
- PSSD is real, under-researched, and often permanent.
- The medical and regulatory communities have failed to warn, study, and support those affected.
- People must be empowered to ask questions, to demand long-term data, and to seek safer solutions for mental health challenges.
Resources & Advocacy:
Rosie's PSSD Network gathers research, survivor stories, and funds lobbying for change—offering hope and solidarity for sufferers.
Listen to the Full Episode
Available on the iHeartRadio app, Apple Podcasts, YouTube, and Rumble. For support and more information, search for the PSSD Network.
Note: This summary omits advertisement, intro, and outro content to focus on the episode’s key insights. All quotes and timestamps reflect the original tone and language.
